JAMA Otolaryngology–Head & Neck Surgery : Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
JAMA Network
00:00
Advances in Personalized Care and Immunotherapy for HNSCC
This chapter highlights the significance of personalized care and intensified surveillance in treating HPV-negative head and neck squamous cell carcinoma. It also discusses the promise of neoadjuvant immunotherapies and the evolving strategies in evaluating treatment efficacy through immune response.
Transcript
Play full episode
